Tuoxin Pharmaceutical Group Co.,Ltd. 301089.SZ Stock
Tuoxin Pharmaceutical Group Co.,Ltd. Price Chart
Tuoxin Pharmaceutical Group Co.,Ltd. 301089.SZ Financial and Trading Overview
| Tuoxin Pharmaceutical Group Co.,Ltd. stock price | 38.12 CNY |
| Previous Close | 69.9 CNY |
| Open | 70 CNY |
| Bid | 68.75 CNY x N/A |
| Ask | 68.76 CNY x N/A |
| Day's Range | 68.75 - 70.85 CNY |
| 52 Week Range | 52.53 - 147.47 CNY |
| Volume | 4.39M CNY |
| Avg. Volume | 6.57M CNY |
| Market Cap | 8.67B CNY |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 15.2146015 |
| EPS (TTM) | 3.81 CNY |
| Forward Dividend & Yield | 0.4 (0.57%) |
| Ex-Dividend Date | June 6, 2023 |
| 1y Target Est | N/A |
301089.SZ Valuation Measures
| Enterprise Value | 8.2B CNY |
| Trailing P/E | 15.2146015 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.1838536 |
| Price/Book (mrq) | 5.1187196 |
| Enterprise Value/Revenue | 6.801 |
| Enterprise Value/EBITDA | 11.491 |
Trading Information
Tuoxin Pharmaceutical Group Co.,Ltd. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -42.35% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 147.47 CNY |
| 52 Week Low | 52.53 CNY |
| 50-Day Moving Average | 70.84 CNY |
| 200-Day Moving Average | 74.89 CNY |
301089.SZ Share Statistics
| Avg. Volume (3 month) | 6.57M CNY |
| Avg. Daily Volume (10-Days) | 5.55M CNY |
| Shares Outstanding | 126M |
| Float | 48.3M |
| Short Ratio | N/A |
| % Held by Insiders | 75.54% |
| % Held by Institutions | 2.18% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.4 |
| Trailing Annual Dividend Yield | 0.57% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.0224 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 46.62% |
| Operating Margin (ttm) | 55.63% |
| Gross Margin | 70.78% |
| EBITDA Margin | 59.18% |
Management Effectiveness
| Return on Assets (ttm) | 24.42% |
| Return on Equity (ttm) | 39.90% |
Income Statement
| Revenue (ttm) | 1.21B CNY |
| Revenue Per Share (ttm) | 9.52 CNY |
| Quarterly Revenue Growth (yoy) | 325.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | 713.9M CNY |
| Net Income Avi to Common (ttm) | 562.4M CNY |
| Diluted EPS (ttm) | 4.52 |
| Quarterly Earnings Growth (yoy) | 969.99% |
Balance Sheet
| Total Cash (mrq) | 613.94M CNY |
| Total Cash Per Share (mrq) | 4.87 CNY |
| Total Debt (mrq) | 10.01M CNY |
| Total Debt/Equity (mrq) | 0.59 CNY |
| Current Ratio (mrq) | 3.94 |
| Book Value Per Share (mrq) | 13.435 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 377.98M CNY |
| Levered Free Cash Flow (ttm) | 154.91M CNY |
Profile of Tuoxin Pharmaceutical Group Co.,Ltd.
| Country | China |
| State | N/A |
| City | Xinxiang |
| Address | No. 515, Kelong Avenue |
| ZIP | 453000 |
| Phone | 86 37 3635 1918 |
| Website | https://www.tuoxinpharm.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1491 |
Tuoxin Pharmaceutical Group Co.,Ltd. engages in the research, development, production, and sale of chemical synthesis, biological fermentation nucleoside (acid) APIs, and pharmaceutical intermediates in China and internationally. It offers purine base, pyrimidine base, nucleosides, nucleotide, deoxynucleosides, dehyfrated nucleoside, 2'-modified, Cybinucleoside, and sugar series, and Azvudine intermediate. The company also provides Disodium 5'-cytidylate, Disodium 5'-uridylate, 5'-Adenosine monophosphate, and D-ribose, as well as citicoline sodium, ribavir Lin, inosine, acyclovir, cytosine, 5-fluorocytosine, cytidine, and other APIs and pharmaceutical intermediates. The company was founded in 2001 and is based in Xinxiang, China.
Q&A For Tuoxin Pharmaceutical Group Co.,Ltd. Stock
What is a current 301089.SZ stock price?
Tuoxin Pharmaceutical Group Co.,Ltd. 301089.SZ stock price today per share is 38.12 CNY.
How to purchase Tuoxin Pharmaceutical Group Co.,Ltd. stock?
You can buy 301089.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Tuoxin Pharmaceutical Group Co.,Ltd.?
The stock symbol or ticker of Tuoxin Pharmaceutical Group Co.,Ltd. is 301089.SZ.
Which industry does the Tuoxin Pharmaceutical Group Co.,Ltd. company belong to?
The Tuoxin Pharmaceutical Group Co.,Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Tuoxin Pharmaceutical Group Co.,Ltd. have in circulation?
The max supply of Tuoxin Pharmaceutical Group Co.,Ltd. shares is 126.54M.
What is Tuoxin Pharmaceutical Group Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
Tuoxin Pharmaceutical Group Co.,Ltd. PE Ratio is 10.00524900 now.
What was Tuoxin Pharmaceutical Group Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
Tuoxin Pharmaceutical Group Co.,Ltd. EPS is 3.81 CNY over the trailing 12 months.
Which sector does the Tuoxin Pharmaceutical Group Co.,Ltd. company belong to?
The Tuoxin Pharmaceutical Group Co.,Ltd. sector is Healthcare.